Cost-Effectiveness of Biologics in Early Rheumatoid Arthritis

被引:6
作者
Finckh, Axel [1 ]
Bansback, Nick [2 ]
Liang, Matthew H. [3 ]
机构
[1] Univ Hosp Geneva, CH-1205 Geneva, Switzerland
[2] Univ British Columbia, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
THERAPY;
D O I
10.7326/0003-4819-152-5-201003020-00018
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:333 / 334
页数:2
相关论文
共 4 条
[2]
Safety of low dose glucocorticoid treatment in rheumatoid arthritis:: published evidence and prospective trial data [J].
Da Silva, JAP ;
Jacobs, JWG ;
Kirwan, JR ;
Boers, M ;
Saag, KG ;
Inês, LBS ;
de Koning, EJP ;
Buttgereit, F ;
Cutolo, M ;
Capell, H ;
Rau, R ;
Bijlsma, JWJ .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (03) :285-293
[3]
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents A Cost-Effectiveness Analysis [J].
Finckh, Axel ;
Bansback, Nick ;
Marra, Carlo A. ;
Anis, Aslam H. ;
Michaud, Kaleb ;
Lubin, Stanley ;
White, Marc ;
Sizto, Sonia ;
Liang, Matthew H. .
ANNALS OF INTERNAL MEDICINE, 2009, 151 (09) :612-W198
[4]
Appropriate and inappropriate use of oral glucocorticoid therapy in rheumatoid arthritis [J].
Maillefert, JF .
JOINT BONE SPINE, 2006, 73 (03) :234-235